Diagnosis, evolution and treatment of craneofaringiomas

Descripción del Articulo

Objective: To describe the clinical and metabolic characteristics of craniopharyngiomas. Material and methods: To descriptive, cross-sectional, retrospective study of 10 cases of sellar craniopharyngiomas of those who were attended in author´s private practice, collected from january 2 to march 31,...

Descripción completa

Detalles Bibliográficos
Autor: Garmendia Lorena, Fausto
Formato: artículo
Fecha de Publicación:2025
Institución:Fundación Instituto Hipólito Unanue
Repositorio:Diagnóstico
Lenguaje:español
OAI Identifier:oai:revistadiagnostico.fihu.org.pe:article/569
Enlace del recurso:https://revistadiagnostico.fihu.org.pe/index.php/diagnostico/article/view/569
Nivel de acceso:acceso abierto
Materia:Hipotálamo
hipófisis
craneofaringiomas
Hypothalamus. pituitary
craniopharyngiomas
id REVFIHU_3d1d8aaa22b3dcd0e97e00bab59139d6
oai_identifier_str oai:revistadiagnostico.fihu.org.pe:article/569
network_acronym_str REVFIHU
network_name_str Diagnóstico
repository_id_str
dc.title.none.fl_str_mv Diagnosis, evolution and treatment of craneofaringiomas
Diagnóstico, evolución y tratamiento de los craneofaringiomas
title Diagnosis, evolution and treatment of craneofaringiomas
spellingShingle Diagnosis, evolution and treatment of craneofaringiomas
Garmendia Lorena, Fausto
Hipotálamo
hipófisis
craneofaringiomas
Hypothalamus. pituitary
craniopharyngiomas
title_short Diagnosis, evolution and treatment of craneofaringiomas
title_full Diagnosis, evolution and treatment of craneofaringiomas
title_fullStr Diagnosis, evolution and treatment of craneofaringiomas
title_full_unstemmed Diagnosis, evolution and treatment of craneofaringiomas
title_sort Diagnosis, evolution and treatment of craneofaringiomas
dc.creator.none.fl_str_mv Garmendia Lorena, Fausto
author Garmendia Lorena, Fausto
author_facet Garmendia Lorena, Fausto
author_role author
dc.subject.none.fl_str_mv Hipotálamo
hipófisis
craneofaringiomas
Hypothalamus. pituitary
craniopharyngiomas
topic Hipotálamo
hipófisis
craneofaringiomas
Hypothalamus. pituitary
craniopharyngiomas
description Objective: To describe the clinical and metabolic characteristics of craniopharyngiomas. Material and methods: To descriptive, cross-sectional, retrospective study of 10 cases of sellar craniopharyngiomas of those who were attended in author´s private practice, collected from january 2 to march 31, 2023. Information is given on age, weight, height, BMI, blood pressure,concentrations of prolactin (PRL), thyrotrophic hormone (TSH), luteotrophic hormone (LH), follicle-stimulating hormone (FSH), somatotropin (STH), thyroxine (T4), triiodo-thyronine (T3), cortisol (F), testosterone (T) in men, estradiol (E2) in women, glucose (G). Stimulatory tests with TRH, GnRH, insulin hypoglycemia, x-rays, ocular campimetry and treatment. Results: 30%women, 28.1±19,5 years old, weight 42.9±12,0 kg, height 1.35±0,12 m, BMI 23.3±3,91 BP 108.0/73.8 mmHg, PRL 26±3 ng/ml, STH 0.47±0.53 ng/ml ml, TSH 5.3±2.4mIU/L, LH 0.92±0.67IU/L, T4 4.8±3.7 ug/dl, T3 100±10 ng/dl, F 3.5 ±3 .78ug/dl, T1.76±1.26 ng/dL, E2 15.7±6.03 pg/ml G 79.3±6.15. TRH test: 7, 2.9, 4.2 mIU/L TSH. GnRH test: 1.09, 1.95, 3.03, 3.05, 1.17 IU/L LH. Insulin hypoglycemia: 0.43, 0.62, 0.47, 0.4, 0.43 ng/ml STH; 3.5, 4.17, 6.2, 6.43, 5.47 ug/dL cortisol. All showed an increasein the sella turcica, several with calcifications in the cystic images. The majority had vision impairment that led to blindness. They underwent transsphenoidal hypophysectomy. Two patients developed diabetes insipidus before the quirurgic treatment. Conclusions: Craniopharyngiomas had basal hormonal concentrations in the normal range and limited responses to stimulatory tests.
publishDate 2025
dc.date.none.fl_str_mv 2025-05-18
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://revistadiagnostico.fihu.org.pe/index.php/diagnostico/article/view/569
10.33734/diagnostico.v64i1.569
url https://revistadiagnostico.fihu.org.pe/index.php/diagnostico/article/view/569
identifier_str_mv 10.33734/diagnostico.v64i1.569
dc.language.none.fl_str_mv spa
language spa
dc.relation.none.fl_str_mv https://revistadiagnostico.fihu.org.pe/index.php/diagnostico/article/view/569/542
dc.rights.none.fl_str_mv Derechos de autor 2025 Fausto Garmendia Lorena
https://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Derechos de autor 2025 Fausto Garmendia Lorena
https://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Fundación Instituto Hipólito Unanue
publisher.none.fl_str_mv Fundación Instituto Hipólito Unanue
dc.source.none.fl_str_mv Diagnóstico; Vol. 64 No. 1 (2025); e569
Diagnostico; Vol. 64 Núm. 1 (2025); e569
1018-2888
2709-7951
10.33734/diagnostico.v64i1
reponame:Diagnóstico
instname:Fundación Instituto Hipólito Unanue
instacron:FIHU
instname_str Fundación Instituto Hipólito Unanue
instacron_str FIHU
institution FIHU
reponame_str Diagnóstico
collection Diagnóstico
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1845890288890937344
spelling Diagnosis, evolution and treatment of craneofaringiomasDiagnóstico, evolución y tratamiento de los craneofaringiomasGarmendia Lorena, FaustoHipotálamohipófisiscraneofaringiomasHypothalamus. pituitarycraniopharyngiomasObjective: To describe the clinical and metabolic characteristics of craniopharyngiomas. Material and methods: To descriptive, cross-sectional, retrospective study of 10 cases of sellar craniopharyngiomas of those who were attended in author´s private practice, collected from january 2 to march 31, 2023. Information is given on age, weight, height, BMI, blood pressure,concentrations of prolactin (PRL), thyrotrophic hormone (TSH), luteotrophic hormone (LH), follicle-stimulating hormone (FSH), somatotropin (STH), thyroxine (T4), triiodo-thyronine (T3), cortisol (F), testosterone (T) in men, estradiol (E2) in women, glucose (G). Stimulatory tests with TRH, GnRH, insulin hypoglycemia, x-rays, ocular campimetry and treatment. Results: 30%women, 28.1±19,5 years old, weight 42.9±12,0 kg, height 1.35±0,12 m, BMI 23.3±3,91 BP 108.0/73.8 mmHg, PRL 26±3 ng/ml, STH 0.47±0.53 ng/ml ml, TSH 5.3±2.4mIU/L, LH 0.92±0.67IU/L, T4 4.8±3.7 ug/dl, T3 100±10 ng/dl, F 3.5 ±3 .78ug/dl, T1.76±1.26 ng/dL, E2 15.7±6.03 pg/ml G 79.3±6.15. TRH test: 7, 2.9, 4.2 mIU/L TSH. GnRH test: 1.09, 1.95, 3.03, 3.05, 1.17 IU/L LH. Insulin hypoglycemia: 0.43, 0.62, 0.47, 0.4, 0.43 ng/ml STH; 3.5, 4.17, 6.2, 6.43, 5.47 ug/dL cortisol. All showed an increasein the sella turcica, several with calcifications in the cystic images. The majority had vision impairment that led to blindness. They underwent transsphenoidal hypophysectomy. Two patients developed diabetes insipidus before the quirurgic treatment. Conclusions: Craniopharyngiomas had basal hormonal concentrations in the normal range and limited responses to stimulatory tests.Objetivo: Describir las características clínicas y metabólicas de los craneofaringiomas, tumores congénitos, restos de la bolsa de Rathke, que suelen aparecer encima de la glándula pituitaria. Material y métodos: Estudio descriptivo, transversal, retrospectivo de 10 historias clínicas de craneofaringiomas sellares, de pacientes que asistieron a la práctica privada del autor. Se informa sobre la edad, peso, talla, IMC, presión arterial, concentraciones de prolactina (PRL), hormona tirotrófica (TSH), luteotrófica (LH), folículo-estimulante (FSH), somatotropina (STH), tiroxina (T4), triiodo-tironina (T3), cortisol (F), testosterona (T) en varones, estradiol (E2) en mujeres, glucosa (G). Pruebas estimulatorias con TRH, GnRH, hipoglicemia insulínica, radiografías, campimetrías oculares y tratamiento. Resultados: 30% mujeres, 28,1±19,5 años, peso 42,9±12,0 kg, talla 1.35±0,12 m, IMC 23,3±3,91 PA 108,0/73,8 mmHg, PRL 26±3 ng/ml, STH 0,47±0,53 ng/ml, TSH 5,3±2,4 mUI/L, LH 0,92±0,67UI/L, T4 4,8±3,7 ug/dl, T3 100±10 ng/dl , F 3,5 ±3,78ug/dl, T 1,76±1,26 ng/dL, E2 15,7±6,03 pg/ml G 79,3±6,15. Prueba TRH: 7, 2,9, 4,2 mUI/L de TSH. Prueba GnRH: 1,09, 1,95, 3,03, 3,05, 1,17 UI/L de LH. Hipoglicemia insulínica: 0,43, 0,62, 0,47, 0,4, 0,43 ng/ml de STH; 3,5, 4,17, 6,2, 6,43, 5,47 ug/dL de cortisol. Todos mostraron incremento de la silla turca, varios con calcificaciones en lasimágenes quísticas. La mayoría tuvo compromiso de la visión que llegó hasta la ceguera. Fueron sometidos a hipofisectomía transesfenoidal. Dos pacientes desarrollaron diabetes insípida antes del tratamiento quirúrgico. Conclusiones: Los craneofaringiomas tuvieron concentraciones hormonales basales dentro del rango normal y respuestas limitadas a las pruebas estimulatorias.Fundación Instituto Hipólito Unanue2025-05-18info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://revistadiagnostico.fihu.org.pe/index.php/diagnostico/article/view/56910.33734/diagnostico.v64i1.569Diagnóstico; Vol. 64 No. 1 (2025); e569Diagnostico; Vol. 64 Núm. 1 (2025); e5691018-28882709-795110.33734/diagnostico.v64i1reponame:Diagnósticoinstname:Fundación Instituto Hipólito Unanueinstacron:FIHUspahttps://revistadiagnostico.fihu.org.pe/index.php/diagnostico/article/view/569/542Derechos de autor 2025 Fausto Garmendia Lorenahttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessoai:revistadiagnostico.fihu.org.pe:article/5692025-08-24T00:19:54Z
score 13.325744
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).